Medicines for Malaria Venture (MMV) 170d ago

At the 2025 ASTMH Annual Meeting, Paul Willis, MMV's VP Head of Early Development, joined the Alan J. Magill Malaria Eradication Symposium to share insights into using AI to support and accelerate drug discovery, including the Drug Design for Global Health platform (dd4gh), currently under development by MMV and deepmirror. Learn more about dd4gh: https://www.mmv.org/newsroom/news-resources-search/medicines-malaria-venture-and-deepmirror-join-forces-adapt-machine Watch the full symposium: https://www.astmh.org/ASTMH/media/2025-Annual-Meeting/Symposium-17.mp4